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S[14-26] min, p¼0.068)}, major access site bleeding complications (0.0% vs 1.3%,
p>0.99) and procedural success (91% vs 100%, p¼0.22) in the radial and the femoral
group respectively. However, in-hospital stay [1 (0-5) vs 1 (0-20) days, p¼0.04)] was
slightly higher following femoral approach. A temporary wire was placed in 10% of
femoral patients. No in-hospital death was observed.
Conclusions: This study shows that the radial artery approach with the 7.5F SGC is at
least as safe and effective as the conventional femoral approach for performing HSRA
facilitated PCI.
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Background: To report the incidence and predictors of moderate/severe radial artery
spasm (RAS) in patients undergoing cardiovascular percutaneous procedures through
a transradial approach (TRA) in center with TRA expertise. Data regarding the actual
rate of clinically meaningful RAS are limited due to difference in study designs and
operator expertise.
Methods: The RAS registry, an international (14 centers from Argentina, Chile, India,
Indonesia, Macedonia, The Netherlands and United States of America) registry that
included 1868 patients undergoing TRA cardiovascular procedures (63.5% diagnostic
and 56.5% therapeutic).All selected centers used TRA as default strategy in the
cardiac catheterization laboratory. Throughout 2012, each center included all
consecutive TRA cases (during a two-month period) into a dedicated database
covering clinical characteristics as well as procedural topics related to TRA patterns
and RAS occurrence.
Results: The incidence of moderate/severe RAS was 2.7%. Only 0.7% of
patients required crossover (8 to transfemoral and 5 to contralateral TRA). Patients
with moderately/severe spasm were more frequently females, had a history of dysli-
pidemia, received more often a 7F sheath and more puncture attempts than patients
without spasm. By multivariate analysis, the need for more than one attempt and the
use of a 7 F sheath were independent predictors of the development of moderate/
severe RAS.
Conclusions: The incidence of moderate/severe RAS is low in centers with a default
TRA. Its development appears to be strongly related to the numbers of puncture
attempts and the use of large sheaths.Baseline and procedural characteristics in patients who required cross-over
P
at
ie
nt
C
O
A
g
e
G
en
de
r
R
A
S
R
A
S
A
lle
n'
s
Te
st
P
ro
ce
du
re
P
un
ct
ur
e
In
tr
aa
rt
er
ia
l
S
he
at
h
To
ta
l
La
rg
es
t
S
ev
er
it
y
on
se
t
at
te
m
pt
s
C
oc
k
ta
il
si
ze
ca
th
et
er
ca
th
et
er
1 F 86 Male Grade 4 DA abnormal PCI 1 NTG,VP 5 3 6
2 F 69 Female Grade 3 DA Not done PCI 1 None 6 1 6
3 F 72 Male Grade 3 1st catheter Not done CA 1 None 6 1 5
4* F 80 Female No —— Not done PCI 1 None 6 2 6
5* F 81 Female No ————— Not done PCI >1 None 6 3 6
6 F 59 Male Grade 3 3rd catheter Normal CA 1 NTG 5 3 5
7 F 52 Female Grade 4 Puncture Not done CA >3 None 5 1 4
8** F 89 Female Grade 3 Puncture Not done CA 1 NTG,VP 5 1 5
9 R 53 Male Grade 4 Puncture Not done CA 1 VP 6 2 6
10* R 70 Male Grade 4 4th catheter Not done CA >3 Nicardipine 5 4 5
11** R 80 Male Grade 3 Puncture Normal PCI >3 NTG 6 2 6
12 R 88 Female Grade 2 1st catheter Normal CA 2 NTG 5 2 5
13 R 52 Male Grade 3 Puncture Not done PCI >3 Not done — — —
CO: indicates cross-over, R: radial CO, F: femoral CO; DA: data unavailable; PCI: percutaneous
coronary intervention, CA: coronary angiogram. NTG: nitroglycerine, VP: verapamil.
*Presence of severe tortuosity of supra-aortic vessels.
**Left radial access.
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Background: Radial artery spasm (RAS) is the most common complication
during transradial procedures (TRP). Different spasmolytic drugs are used alone
or in combination to avoid this complication. Radial hydrophilic sheaths offer less
traumatic vascular access, and dedicated transradial catheters help avoid the use
of larger French catheters and multiple exchanges, commonly associated with
RAS. All these improvements, added to an ample learning curve in TRP,
transformed a RAS into a less frequent complication. Because there is not enough
evidence to support the non-use of spasmolytic drugs for TRP in daily practice, known
as non-cocktail strategy, we assessed the hypothesis that the use of dedicated trans-
radial devices by highly experienced operators makes spasmolytic cocktails
unnecessary.
Methods: Throughout 2012 a multicenter transradial registry (RAS Registry) was
created including prospectively and consecutively all TRP (diagnostic and therapeutic)
in 14 highly experienced hospitals in 7 countries. We sub-analyzed the incidence of
RAS in those patients who had received one or more spasmolytic drugs (group 1)
compared to those without any spasmolytic drug (non-cocktail strategy) (group 2).
Incidence of RAS was classiﬁed as mild (minimal local pain), moderate (signiﬁcant
local pain with possibility of moving the catheter to complete the procedure), and
severe (cross-over to another access due to local pain during catheter movements
compelling operator to stop the procedure or catheter trapping that does not allow
proper handling).
Results: A total of 1,926 patients were analyzed. 1,552 (80.6%) belonged to
group 1 and 374 (19.4%) belonged to group 2. There were no statistical dif-
ferences in patient and procedural characteristics between the two groups.
RAS (mild/moderate/severe) incidence was: group 1: 10.9% and group 2: 9.9%
(p¼0.64) and RAS (severe only) incidence was: group 1: 0.83% and group 2: 1.06%
(p¼0.92).
Conclusions: Provided procedures are performed by highly experienced operators,
a non-cocktail strategy for TRP can be performed safely and without an increase of
RAS incidence if compared with patients on spasmolytic drugs, with the possibility of
avoiding the side effects of these drugs.TCT-271
Use of the sheathless guide catheter for transradial approach in primary
percutaneous coronary intervention for acute ST-segment elevation myocardial
infarction
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Background: Transradial approach (TRA) is effective treatment of primary percu-
taneous coronary intervention (PPCI) for acute ST-segment elevation myocardial
infarction (STEMI). Its safety and effectiveness are comparable to the trans-
femoral approach in PPCI. We routinely conduct PPCI via TRA with sheathless guide
catheter for patients with STEMI. Using the sheathless guide catheter makes it
possible to perform PCI without an introducer sheath. The sheathless catheter has
a larger lumen without increasing an external diameter, as compared with conven-
tional guide catheter. Due to this advantage, use of the sheathless catheter may
contribute to further expanding the type of cases performed PCI via TRA. We eval-
uated the safety and effectiveness of use of sheathless catheter for TRA in PPCI for
STEMI.
Methods: We conducted PPCI in 635 patients presenting STEMI between September
2010 and May 2013. We excluded 94 patients from this study due to use of
conventional guide catheter (n¼16), transfemoral approach (n¼78). We analyzed data
of the other 541 patients to evaluate safety and effectiveness of TRA with sheathless
catheters. Primary endpoints of this study comprised crossover rates to another
vascular access site, and acute procedural success rates. Secondary endpoints were
total procedure duration, ﬂuoroscopy times and contrast use. Acute procedural success
was deﬁned as a thrombolysis in myocardial infarction (TIMI) ﬂow grade 3 or an
improvement of the TIMI ﬂow of 2 grades and 30% or less stenosis in the culprit
lesion at the end of the procedure.ember 1, 2013 j TCT Abstracts/POSTER/Vascular Access and Closure
www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PM
P
O
S
T
E
R
SResults: Access site cross over was needed in 1 patient (0.002%), and con-
version from sheathless guiding catheter to conventional guiding catheter in 1 patient
(0.002%). Acute procedural success rate was 95. 9%. The median duration of
the procedures was 50min (IQR 41-65). The median time of ﬂuoroscopy was
16.5min(IQR 12.7-23.6). The median contrast media use was 136ml (IQR 110-160).
Guiding catheter-induced coronary artery dissection occurred in 1 patient.
Conclusions: Routine use of the Sheathless guide catheter for TRA in PPCI
for STEMI is feasible with a low crossover rate and a high rate of procedural
success.
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Background: Up to our knowledge, there's no data investigating the three different
approaches (Transbrachial (TBA), Transradial (TRA) and Transfemoral (TFA) for
PCI .Coping with our daily needs for diversity of tools and approaches we explore our
extensive experiences with the different PCI accesses.
Methods: This retrospective observational,single center trial investigated 4955 CAD
patients underwent coronary revascularization through one of the studied approaches
between April 2006 to June 2012. After application of inclusion and exclusion
criteria.A total of 1102(22.2%),2797(56.4%)and,1054(21.2%)Patients were distrib-
uted through(TBA),TRA)and(TFA)accesses respectively.All patients were retrospec-
tively evaluated regards the predeﬁned primary safety endpoint(In hospital Cardiac
death,MI,stroke,major access site hematoma and/or bleeding)and efﬁcacy endpoints
(Access and procedure success/time,contrast volume,cross over rate and access site
complications.
Results: Over the 7 year study period,our results showed that both TBA and TRA
associated with higher procedural success compared with TFA(P¼0.0001)with no
signiﬁcant difference in access success and time.Both TBA and TRA groups have
shorter ﬂuoroscopy time(P¼0.0001).Regards the safety endpoints, our results
showed that TFA patients have higher rate of MACE and In–Hospital cardiac death
compared with TRA patients(p¼0.008 and 0.01 for MACE and cardiac death
respectively).Such difference is not encountered between TBA and either TRA or
TFA groups,however there was no signiﬁcant difference in MI,stroke,emergency
CABG.TFA group has signiﬁcantly higher incidence of major access site hematoma
(p¼0.0001).Both TBA and TFA groups have higher proportions of access site
pseudoaneurysm(P¼0.001).Primary Safety and efﬁcacy Endpoints between TBA,TRA and,TFA.
TBA (1102) TRA(2797) TFA(1054) P .value
MACE(%) 21(1.9)a,b 33(1.2)a 27(2.6)b 0.008*
Cardiac Death (%) 1(0.1)a,b 2(0.1)a 6(0.6)b 0.001*
Acute MI 20(1.8) 32(1.1) 22(2.1) 0.06
Stroke(%) 2 (0.2) 3 (0.1) 5(0.5) 0.07
Major access site Hematoma (%) 3(0.3)a 4(0.1)a 13(1.2)b 0.0001*
Aneurysm/Pseudo aneurysm (%) 8(0.7)a 1(0.01)b 5(0.5)a 0.001*
Procedure Success(%) 1080(98)a 2752(98.4)a 1008(95.6)b 0.0001*
Procedure time(min) 132.39 9.5 131.53  7.3 131.4  7.8 0.09
Fluoroscopy time (min) 21.1  14.5a 21.8 15.7a 34.7 26.9b 0.000*
Contrast Volume(mL) 111.9 60.1a 124 66.3 171 87.5 0.000x
Data are presented as mean+SD, or the number of patients/arteries (percentage);
TBA¼transbrachial approach; TRA¼transradial aaproach;TFA¼transfemoral approach; *The
same superscript letter denotes column proportions which do not differ signiﬁcantly from
each other at the .05 level,Different superscript letters means signiﬁcant difference between
its column proportions.Conclusions: Based on the previous data, transbrachial approach for PCI could be
a good alternative for the standard of care approaches with considerable safety and
efﬁcacy.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-273
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Background: Use of bleeding avoidance strategies (BAS) such as transradial
access, bivalirudin, and femoral closure devices have been shown to lower bleeding
events after PCI but used most often in those at lowest risk of bleeding. Patient
characteristics that deter use of BAS in higher risk patients for bleeding are not clearly
established.
Methods: Patients undergoing PCI at four University of Pittsburgh Medical Center
afﬁliated hospitals were enrolled in a hospital-based registry and followed prospec-
tively beginning in October 2011. Bleeding events and bleeding risk score (BRS) were
deﬁned by NCDR criteria and deﬁnitions. Low risk of bleeding deﬁned as score<13
and high risk of bleeding as score13.
Results: Among 2178 consecutive PCI patients (66.7% for acute coronary syndrome),
978 patients had a calculated BRS of <13 and 1200 patients 13. BAS use more
likely in the low risk group (91.1 vs 83.0%, p¼0.0001). Speciﬁc strategy used in the
low and high-risk groups were femoral access closure only in 23.5 vs 28.2% (p¼0.01),
bivalirudin only in 21.6 vs 21.1% (p¼0.78), transradial access only in 4.1 vs 3.8%
(p¼0.68), and a combination of BAS in 41.9 vs 30% (p¼0.0001). Among the high
risk group, logistic regression was used to determine the independent risk factors
associated with use of BAS (Figure 1).Conclusions: Utilization of a BAS has been increasingly advocated for especially in
high-risk patients for bleeding. However, recognizing deterrents to utilization allows
for understanding if use is even feasible and further studies are necessary to study the
safety and efﬁcacy of BAS in higher risk patients.
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Stenting and Facilitated Femoral Hemostasis with a Closure Device
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Background: Despite advances in interventional cardiology, and that safety and
feasibility of outpatient percutaneous coronary intervention (PCI) has been previously
demonstrated, overnight stay after PCI remains the standard of care in the United
States. The study aims to compare outcomes, patient satisfaction, and cost of same day
(SD) vs. delayed hospital discharge (DD) after PCI-stenting and femoral hemostasis
with a vascular closure device (StarClose or ProGlide).
Methods: Consecutive patients undergoing coronary angiography (n¼2,480) at
University of Southern California Hospitals were screened; 493 patients were con-
sented for inclusion. Four hours following PCI, 100 patients were randomized to SD
(n¼50) or DD (n¼50). Patients were followed for one month and patient satisfaction
surveys completed at 24 hours and one-month post discharge. Cost savings were
calculated based on Medicare payment rates.
Results: SD and DD groups were well distributed with similar baseline demographic
and angiographic characteristics. Mean age was 58.18.8, 86% were male, 16%
smokers, 44% diabetic, 41% had history of MI and 31% CRI. NSTEMI or
unstable angina (UA) was the presentation in 30% of SD vs. 44% of DD
patients (p¼0.2) and all other patients had stable angina (SA) (70% in DD vs. 56% in
SD, p¼0.15). Multivessel stenting was performed in 74% and 60% of SD and
DD groups, respectively (p¼0.14). At 30 days post-discharge, the primary end
point (death, myocardial infarction or repeat revascularization) occurred in one
DD patient (2%) vs. two SD patients (4%), p¼1.0. The secondary end points ofacts/POSTER/Vascular Access and Closure B89
